116 related articles for article (PubMed ID: 20960507)
1. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
Hermelink K
Cancer; 2011 Mar; 117(5):1103; author reply 1103-4. PubMed ID: 20960507
[No Abstract] [Full Text] [Related]
2. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
[TBL] [Abstract][Full Text] [Related]
3. 'Chemobrain' in breast carcinoma?: a prologue.
Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
[TBL] [Abstract][Full Text] [Related]
4. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
5. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study.
Hermelink K; Küchenhoff H; Untch M; Bauerfeind I; Lux MP; Bühner M; Manitz J; Fensterer V; Münzel K
Psychooncology; 2010 Dec; 19(12):1321-8. PubMed ID: 20127909
[TBL] [Abstract][Full Text] [Related]
6. Cognitive problems after chemotherapy for breast cancer.
Harv Womens Health Watch; 2002 Oct; 10(2):5-6. PubMed ID: 12393318
[No Abstract] [Full Text] [Related]
7. Cognitive deficits are usually mild in patients with breast cancer after chemotherapy.
Barton MK
CA Cancer J Clin; 2013 Jan; 63(1):3-4. PubMed ID: 23169539
[No Abstract] [Full Text] [Related]
8. Assessing cognitive dysfunction in breast cancer: what are the tools?
Freeman JR; Broshek DK
Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S91-9. PubMed ID: 12533269
[TBL] [Abstract][Full Text] [Related]
9. Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.
Biglia N; Bounous VE; Malabaila A; Palmisano D; Torta DM; D'Alonzo M; Sismondi P; Torta R
Eur J Cancer Care (Engl); 2012 Jul; 21(4):485-92. PubMed ID: 22211832
[TBL] [Abstract][Full Text] [Related]
10. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.
Weis J; Poppelreuter M; Bartsch HH
Psychooncology; 2009 Jul; 18(7):775-82. PubMed ID: 19061196
[TBL] [Abstract][Full Text] [Related]
11. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature.
Jansen CE; Miaskowski C; Dodd M; Dowling G
Oncol Nurs Forum; 2005 Mar; 32(2):329-42. PubMed ID: 15759070
[TBL] [Abstract][Full Text] [Related]
13. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
Schagen SB; van Dam FS
J Clin Oncol; 2006 Nov; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
[No Abstract] [Full Text] [Related]
14. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.
Kesler SR; Blayney DW
JAMA Oncol; 2016 Feb; 2(2):185-92. PubMed ID: 26633037
[TBL] [Abstract][Full Text] [Related]
15. Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective.
Schagen SB; Muller MJ; Boogerd W; Van Dam FS
Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S100-8. PubMed ID: 12533270
[TBL] [Abstract][Full Text] [Related]
16. Accumulating evidence for the effect of chemotherapy on cognition.
Rodin G; Ahles TA
J Clin Oncol; 2012 Oct; 30(29):3568-9. PubMed ID: 22927529
[No Abstract] [Full Text] [Related]
17. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.
Ferguson RJ; McDonald BC; Saykin AJ; Ahles TA
J Clin Oncol; 2007 Sep; 25(25):3866-70. PubMed ID: 17761972
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer.
Reid-Arndt SA; Hsieh C; Perry MC
Psychooncology; 2010 May; 19(5):535-44. PubMed ID: 19472296
[TBL] [Abstract][Full Text] [Related]
19. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.
Paraska K; Bender CM
Oncol Nurs Forum; 2003; 30(3):473-8. PubMed ID: 12719746
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM
J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]